4D-QSAR analysis of a set of ecdysteroids and a comparison to CoMFA modeling

被引:54
作者
Ravi, M
Hopfinger, AJ
Hormann, RE
Dinan, L
机构
[1] RHeoGene LLC, Spring House, PA 19477 USA
[2] Univ Illinois, Coll Pharm, Lab Mol Modeling & Design MC781, Chicago, IL 60612 USA
[3] Univ Exeter, Dept Biol Sci, Hatherly Labs, Exeter EX4 4PS, Devon, England
来源
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES | 2001年 / 41卷 / 06期
关键词
D O I
10.1021/ci010076u
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The ecdysteroid-responsive Drosophila melanogaster BI, cell line is a prototypical homologous inducible gene expression system. A training set of 71 ecdysteroids, for which the -log(EC50) potencies in the ecdysteroid-responsive BI, cell line were measured, was used to construct 4D-QSAR models. Four nearly equivalent optimum 4D-QSAR models, for two modestly different alignments, were identified (Q(2) = 0.76-0.80). These four models, together with two CoMFA models, were used in consensus modeling to arrive at a three-dimensional pharmacophore. The C-2 and C-22 hydroxyls are identified as hydrogen-bond acceptor sites which enhance activity. A hydrophobic site near C-12 is consistent with increasing activity. The sidechain substituents at C-17 are predicted to adopt semiextended "active" conformations which could fit into a cylinder-shaped binding pocket lined largely with nonpolar residues for enhanced activity. A test set of 20 ecdysteroids was used to evaluate the QSAR models. Two 4D-QSAR models for one alignment were identified to be superior to the others based on having the smallest average residuals of prediction for the prediction set (0.69 and 1.13 -log[EC50] units). The correlation coefficients of the optimum 4D-QSAR models (R-2 = 0.87 and 0.88) are nearly the same as those of the best CoMFA model (R-2 = 0.92) determined for the same training set. However, the cross-validation correlation coefficient of the CoMFA model is less significant (Q(2) = 0.59) than those of the 4D-QSAR models (Q(2) = 0.80 and 0.80).
引用
收藏
页码:1587 / 1604
页数:18
相关论文
共 66 条
[1]   Regulatable systems: applications in gene therapy and replicating viruses [J].
Agha-Mohammadi, S ;
Lotze, MT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1177-1183
[2]   Four-dimensional quantitative structure-activity relationship analysis of a series of interphenylene 7-oxabicycloheptane oxazole thromboxane A2 receptor antagonists [J].
Albuquerque, MG ;
Hopfinger, AJ ;
Barreiro, EJ ;
de Alencastro, RB .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (05) :925-938
[3]   Chimeric receptors as gene switches [J].
Allgood, VE ;
Eastman, EM .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (04) :474-479
[4]  
Anderson WF, 1998, NATURE, V392, P25
[5]  
[Anonymous], 3D QSAR DRUG DESIGN
[6]   Gene silencing as a threat to the success of gene therapy [J].
Bestor, TH .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :409-411
[7]  
CARLSON GR, 1999, Patent No. 99304444
[8]  
*CHEM21 GROUP INC, 2000, 4D QSAR AN US GUID V
[9]   Regulated gene expression systems [J].
Clackson, T .
GENE THERAPY, 2000, 7 (02) :120-125
[10]   ASSESSMENT OF A MICROPLATE-BASED BIOASSAY FOR THE DETECTION OF ECDYSTEROID-LIKE OR ANTIECDYSTEROID ACTIVITIES [J].
CLEMENT, CY ;
BRADBROOK, DA ;
LAFONT, R ;
DINAN, L .
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 23 (01) :187-192